"Ayahuasca-derived DMT study shows positive effects on depression therapy in trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.
PsyPost on MSN
Short-acting psychedelic DMT shows promise as a rapid treatment for major depressive disorder
A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can ...
For those with treatment-resistant depression, traditional methods often fall short. Learn about TMS, a non-invasive option.
Consider a house with the water main half shut. The faucets sputter. The toilet runs all night. The garden wilts. You could call a plumber for the faucet, a landscaper for the garden, a different ...
MedPage Today on MSN
Psychedelic Eased Symptoms of Treatment-Resistant Depression
Findings should be interpreted with caution, given the lack of placebo effect, expert says ...
Forbes contributors publish independent expert analyses and insights. I am a therapist, executive coach and author. The gentle tapping sound reminds me of a woodpecker–rhythmic and purposeful. I'm ...
Teens with depression have to navigate the challenges of living with a mood disorder, along with the usual academic and social pressures of high school. A depression diagnosis may be unsettling, but ...
Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported ...
RESEDA, CA - March 19, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new educational resource ...
Doctronic reports childhood depression affects 2%-3% of children, with symptoms lasting over two weeks; early intervention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results